Search Results

IX Forum on Translational Immunology and Cancer Immuno-therapy (FIT Cancer 9).

Subjects: *IMMUNOLOGY; *TUMOR microenvironment; *FORUMSMADRID (Spain)

• Source: OncoImmunology. 2023Suppl1, Vol. 12, p1-10. 10p.

Record details

Islet cell replacement and transplantation immunology in a mouse strain with inducible diabetes.

• Authors : Bhagchandani, Preksha¹ (AUTHOR); Chang, Charles A.¹ (AUTHOR); Zhao, Weichen¹ (AUTHOR)

Subjects: *TRANSPLANTATION immunology; *ISLANDS of Langerhans; *CELL transplantation

• Source: Scientific Reports. 5/31/2022, Vol. 12 Issue 1, p1-10. 10p.

Record details

ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance.

• Authors : Jang, Su Chul¹; Economides, Kyriakos D.¹; Moniz, Raymond J.¹

Subjects: *DINUCLEOTIDES; *TUMOR immunology; *CELL-mediated cytotoxicity

• Source: Communications Biology. 4/22/2021, Vol. 4 Issue 1, p1-17. 17p.

Record details

Human‐porcine MHC‐I homology allows for antibody cross‐reactivity.

• Authors : Forneris, Nicole¹ (AUTHOR); Levy, Heather¹ (AUTHOR); Burlak, Christopher¹ (AUTHOR)

Subjects: *HLA histocompatibility antigens; *CROSS reactions (Immunology); *MAJOR histocompatibility complex

• Source: HLA: Immune Response Genetics. Aug2020, Vol. 96 Issue 2, p197-201. 5p. 1 Black and White Photograph, 1 Chart.

Record details

Inflamed neutrophils sequestered at entrapped tumor cells via chemotactic confinement promote tumor cell extravasation.

• Authors : Chen, Michelle B.¹; Hajal, Cynthia¹; Benjamin, David C.^2,3

Subjects: *IMMUNOLOGY of inflammation; *NEUTROPHILS; *TUMOR immunology

• Source: Proceedings of the National Academy of Sciences of the United States of America. 7/3/2018, Vol. 115 Issue 27, p7022-7027. 6p.

Record details

Acknowledgements.

Subjects: *TUMOR immunology

• Source: Cancer Immunology, Immunotherapy. Apr2019, Vol. 68 Issue 4, p699-703. 5p.

Record details

Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody.

• Authors : Danbee Ha^1,2; Atsushi Tanaka¹; Tatsuya Kibayashi^1,3

Subjects: *T cells; *TUMOR immunology; *IMMUNOGLOBULINS

• Source: Proceedings of the National Academy of Sciences of the United States of America. 1/8/2019, Vol. 116 Issue 2, p609-618. 10p.

Record details

Intravascular NK/T-cell lymphoma, Epstein-Barr virus positive with multiorgan involvement: a clinical dilemma.

• Authors : Zanelli, Magda¹ ; Mengoli, Maria Cecilia¹ ; Del Sordo, Rachele²

Subjects: *LYMPHOMAS; *TUMOR immunology; *EPSTEIN-Barr virus

• Source: BMC Cancer. 11/15/2018, Vol. 18 Issue 1, p1-8. 8p. 2 Color Photographs, 2 Charts, 2 Graphs.

Record details

Thinking differently about ILCs—Not just tissue resident and not just the same as CD4+ T‐cell effectors.

• Authors : Huang, Yuefeng^1,2 ; Mao, Kairui¹ ; Germain, Ronald N.¹

Subjects: *TUMOR immunology; *CD4 antigen; *T cells

• Source: Immunological Reviews. Nov2018, Vol. 286 Issue 1, p160-171. 12p.

Record details

Targeting tryptophan availability to tumors: the answer to immune escape?

• Authors : Badawy, Abdulla A‐B¹

Subjects: *TRYPTOPHAN; *TUMOR immunology; *ALBUMINS

• Source: Immunology & Cell Biology. Nov2018, Vol. 96 Issue 10, p1026-1034. 9p.

Record details